Ligand Pharmaceuticals Statistics
Total Valuation
Anghami has a market cap or net worth of $23.81 million. The enterprise value is $21.95 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Anghami has 6.69 million shares outstanding. The number of shares has increased by 117.97% in one year.
| Current Share Class | 6.69M |
| Shares Outstanding | 6.69M |
| Shares Change (YoY) | +117.97% |
| Shares Change (QoQ) | +38.77% |
| Owned by Insiders (%) | 13.55% |
| Owned by Institutions (%) | 0.26% |
| Float | 1.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60, with a Debt / Equity ratio of 0.21.
| Current Ratio | 0.60 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -350.69 |
Financial Efficiency
Return on equity (ROE) is -285.53% and return on invested capital (ROIC) is -134.56%.
| Return on Equity (ROE) | -285.53% |
| Return on Assets (ROA) | -53.44% |
| Return on Invested Capital (ROIC) | -134.56% |
| Return on Capital Employed (ROCE) | -83.99% |
| Revenue Per Employee | $419,857 |
| Profits Per Employee | -$341,691 |
| Employee Count | 186 |
| Asset Turnover | 1.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Anghami has paid $1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.93% in the last 52 weeks. The beta is 1.24, so Anghami's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -61.93% |
| 50-Day Moving Average | 5.00 |
| 200-Day Moving Average | 6.49 |
| Relative Strength Index (RSI) | 40.86 |
| Average Volume (20 Days) | 297,947 |
Short Selling Information
The latest short interest is 25,370, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 25,370 |
| Short Previous Month | 9,853 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 1.49% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
In the last 12 months, Anghami had revenue of $78.09 million and -$63.55 million in losses. Loss per share was -$11.03.
| Revenue | 78.09M |
| Gross Profit | -24.02M |
| Operating Income | -61.37M |
| Pretax Income | -15.16M |
| Net Income | -63.55M |
| EBITDA | -55.55M |
| EBIT | -61.37M |
| Loss Per Share | -$11.03 |
Full Income StatementBalance Sheet
The company has $14.15 million in cash and $12.30 million in debt, giving a net cash position of $1.85 million or $0.28 per share.
| Cash & Cash Equivalents | 14.15M |
| Total Debt | 12.30M |
| Net Cash | 1.85M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 58.64M |
| Book Value Per Share | 8.95 |
| Working Capital | -20.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.82 million and capital expenditures -$45,756, giving a free cash flow of -$47.86 million.
| Operating Cash Flow | -47.82M |
| Capital Expenditures | -45,756 |
| Free Cash Flow | -47.86M |
| FCF Per Share | -$7.16 |
Full Cash Flow StatementMargins
Gross margin is -30.76%, with operating and profit margins of -78.59% and -81.38%.
| Gross Margin | -30.76% |
| Operating Margin | -78.59% |
| Pretax Margin | -79.16% |
| Profit Margin | -81.38% |
| EBITDA Margin | -71.13% |
| EBIT Margin | -78.59% |
| FCF Margin | n/a |
Dividends & Yields
Anghami does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -117.97% |
| Shareholder Yield | -117.97% |
| Earnings Yield | -266.95% |
| FCF Yield | -201.04% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 4, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 4, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Anghami has an Altman Z-Score of -2.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.99 |
| Piotroski F-Score | 2 |
